Table 1.
Placebo | ALRV5XR | |
---|---|---|
(N = 23) | (N = 23) | |
Sex | ||
Male | 23 (100%) | 23 (100%) |
Female | 0 (0%) | 0 (0%) |
Age (years) | ||
Mean ( ± SD) | 45·7 ( ± 12·9) | 48·3 ( ± 7·9) |
Range | 22–65 | 32–63 |
Anthropometrics | ||
Height (cm)† | 172·7 (170·3–185·5) | 175·3 (170·5–177·8) |
Weight (kg)† | 80·2 (69·3–90·8) | 81·4 (73·7–93·6) |
BMI (kg/m2)† | 25·1 (22·6–31·2) | 27·1 (23·7–31·8) |
BP (mmHg) | 128·3/84·1 ( ± 13·5/9·9) | 128·1/84·4 ( ± 21·5/17·9) |
Trichometry | ||
Terminal hair density (per cm2) | 141·6 ( ± 66·2) | 139·1 ( ± 68·6) |
Vellus hair density (per cm2) | 139·2 ( ± 62·2) | 123·7 ( ± 66·2) |
Ethnicity | ||
African American | 4 (17·4%) | 4 (17·4%) |
Caucasian | 10 (43·5%) | 7 (30·4%) |
Chinese | 5 (21·7%) | 6 (26·1%) |
Hispanic | 1 (4·3%) | 3 (13%) |
Indian | 1 (4·3%) | 0 (0%) |
Filipino | 0 (0%) | 1 (4·3%) |
Korean | 1 (4·3%) | 0 (0%) |
Mongolian | 0 (0%) | 1 (4·3%) |
Thai | 0 (0%) | 1 (4·3%) |
Vietnamese | 1 (4·3%) | 0 (0%) |
Fitzpatrick Skin Type | ||
I | 3 (13%) | 1 (4·3%) |
II | 3 (13%) | 2 (8·7%) |
III | 10 (43·5%) | 15 (65·2%) |
IV | 2 (8·7%) | 1 (4·3%) |
V | 2 (8·7%) | 1 (4·3%) |
VI | 2 (8·7%) | 3 (13%) |
Unknown | 1 (4·3%) | 0 (0%) |
Diagnosis | ||
AGA | 23 (100%) | 23 (100%) |
TE | 0 (0%) | 0 (0%) |
Hamilton–Norwood Classification | ||
I | 4 (17·4%) | 0 (0%) |
II | 2 (8·7%) | 1 (4·3%) |
IIA | 2 (8·7%) | 1 (4·3%) |
III | 1 (4·3%) | (0%) |
IIIA | 0 (0%) | 1 (4·3%) |
IIIV | 5 (21·7%) | 6 (26·1%) |
IV | 1 (4·3%) | 4 (17·4%) |
V | 0 (0%) | 1 (4·3%) |
VA | 3 (13%) | 2 (8·7%) |
VI | 1 (4·3%) | 0 (0%) |
VII | 2 (8·7%) | 3 (13%) |
Missing | 2 (8·7%) | 4 (17·4%) |
Abbreviations: ± or SD=standard deviation; † Height, Weight and BMI are reported as Median (IQR).